Amphastar Pharmaceuticals Stock Price

-0.89 (-3.07%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 312,009
Bid Price 26.77
Ask Price 31.82
News -
Day High 29.34


52 Week Range


Day Low 28.07
Company Name Stock Ticker Symbol Market Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.89 -3.07% 28.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
28.97 28.07 29.34 28.10 28.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,704 312,009 $ 28.74 $ 8,966,087 - 18.12 - 44.46
Last Trade Time Type Quantity Stock Price Currency
16:48:59 average 824 $ 28.10 USD


Draw Mode:

Amphastar Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.38B 49.02M 31.03M $ 437.77M $ 83.83M 1.25 16.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 13.91k 2.30%

more financials information »

Amphastar Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week27.1729.5627.1028.48240,1740.933.42%
1 Month29.6830.2127.1028.66296,494-1.58-5.32%
3 Months36.5039.0727.1032.47309,608-8.40-23.01%
6 Months36.2044.4627.1034.60466,780-8.10-22.38%
1 Year19.3244.4618.1231.41377,6428.7845.45%
3 Years20.3444.4612.32524.54274,2637.7638.15%
5 Years17.9744.4612.32522.95243,54010.1356.37%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Your Recent History
Amphastar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now